Company
ExpreS2ion Biotech Holding AB
Headquarters: Horsholm, Denmark
Employees: 25
Market Cap
€10.4 Million
EUR as of Jan. 1, 2024
US$11.4 Million
ExpreS2ion Biotech Holding AB Categories
Denmark Healthcare BiotechnologyDenmark Healthcare Denmark Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops, produces, and delivers therapeutics or diagnostic proteins in Denmark and internationally. It is also developing capsid virus-like particle COVID-19 vaccine; influenza vaccine; breast cancer vaccine; and malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
ExpreS2ion Biotech Holding AB has the following listings and related stock indices.
Stock: FSX: 5JD wb_incandescent
Stock: OMX: EXPRS2 wb_incandescent